Pioneering Medicines 02, LLC
CIK: 0002117576
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GENB
Generate Biomedicines, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Pioneering Medicines 02, LLC
Pioneering Medicines 02, LLC (SEC CIK 0002117576) files insider reports with the SEC as 10% Owner of Generate Biomedicines, Inc. (GENB).
Signal8 holds 1 ownership filing by Pioneering Medicines 02, LLC, a Form 3, filed on Mar 12, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Pioneering Medicines 02, LLC's filings is in CAMBRIDGE, MA.
Other insiders filing for Generate Biomedicines, Inc. (GENB)
- ARNOLD FRANCES, Director
- Nally Michael, Chief Executive Officer
- Vessey Rupert, Director
- Grous Beth, Chief People Officer
- Lee Laurie Anne, Chief Medical Officer
- Martin Sean, Chief Legal Officer & GC